{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-014513","form_type":"8-K","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2023-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.698684+00:00","generated_at":"2026-06-19T21:48:10.744129+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Twist Bio annual meeting elects directors, approves say-on-pay, ratifies auditor","bullets":["Keith Crandell and Jan Johannessen elected as Class II directors with 33.9M and 32.2M votes for, respectively.","Non-binding advisory vote to approve NEO compensation passed with 43.4M for, 3.7M against.","Ratification of Ernst & Young as independent auditor for FY2023 approved with 52.0M votes for, 17.6K against.","Approximately 91.92% of total outstanding shares were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-014513","json":"https://secwatch.observer/filing/0001104659-23-014513.json","markdown":"https://secwatch.observer/filing/0001104659-23-014513.md","text":"https://secwatch.observer/filing/0001104659-23-014513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/tm235797d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T21:48:10.744129+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a651e33a9edb69d4ac2b0c413c68d4ca6d6d3e6b","claim":"Twist Bioscience Corp shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-02-07 meeting.","evidence_excerpt":"Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered accounting firm for the fiscal year ending September 30, 2023 by the following votes: Votes For Votes Against Abstentions 52,003,570 17,623 47,382","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-02-07"}],"fact_type":"shareholder_vote"},{"claim_id":"a6c419beda896b9d8566e21d47607acce4b7a40f","claim":"Twist Bioscience Corp shareholders approved Election of Directors at the 2023-02-07 meeting.","evidence_excerpt":"Proposal One — Election of Directors The Company’s stockholders approved the election of two directors to the Company’s Board of Directors (“Board”) as Class II Directors by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Keith Crandell 33,891,453 13,264,841 4,912,281 Jan Johannessen 32,240,144 14,916,150 4,912,281","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-02-07"}],"fact_type":"shareholder_vote"},{"claim_id":"b988aa8abb2c2e833d61c0c42013512741b47e0c","claim":"Twist Bioscience Corp shareholders approved Non-Binding, Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2023-02-07 meeting.","evidence_excerpt":"Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers (“NEOs”) The Company’s stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company’s NEOs by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 43,379,295 3,746,996 30,003 4,912,281","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923014513/0001104659-23-014513-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-02-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}